| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/17/1991 | EP0422215A1 Antibacterial and antimalarial peptides |
| 04/17/1991 | EP0422186A1 Methods for controlling human endothelial cell proliferation and effector functions using oncostatin m |
| 04/17/1991 | EP0422181A1 Method and means for inducing, resp., preventing constriction of the pupil in the eye |
| 04/17/1991 | EP0422124A1 Thermal release of recombinant protein into culture media |
| 04/17/1991 | EP0422115A1 Identification of human t-lymphocyte epitopes in pathogens for vaccine development |
| 04/17/1991 | EP0422104A1 Angiogenic potentiating peptides which potentiate angiogenic factors |
| 04/17/1991 | EP0422049A1 Vector for secretion of proteins directly into periplasm or culture medium |
| 04/17/1991 | EP0422037A1 Immunochemical assay for human granulocyte-macrophage colony stimulating factor |
| 04/17/1991 | EP0416033A4 Macrocyclic chelates and methods of use thereof |
| 04/17/1991 | EP0174999B1 Method for improving expression and method thereto |
| 04/17/1991 | CN1050721A Radiolabeled anticoagulant peptides |
| 04/17/1991 | CN1050720A Anticoagulant peptides |
| 04/17/1991 | CA2267658A1 Use of stem cell factor polypeptide to stimulate growth of epithelial cells |
| 04/17/1991 | CA2267643A1 Use of stem cell factor polypeptide as an anti-hematopoietic disorder agent |
| 04/17/1991 | CA2267626A1 Use of stem cell factor polypeptide to stimulate growth of stromal cells |
| 04/17/1991 | CA2067778A1 Non-infectious hiv-1 particles and uses therefor |
| 04/17/1991 | CA2067363A1 Non-specific dna amplification |
| 04/16/1991 | US5008377 Contacting with nuclear sulfonic acid cation ion exchange resin |
| 04/16/1991 | US5008376 Ultrafiltration using a membrane having permselectivity |
| 04/16/1991 | US5008374 IL-1α derivatives and drugs |
| 04/16/1991 | US5008373 First amino acid sequence for particle formation, second for biological activity; vaccines, diagnosis, purification |
| 04/16/1991 | US5008371 Biologically active polypeptide and use thereof |
| 04/16/1991 | US5008358 Polymer compositions |
| 04/16/1991 | US5008273 Amino acid derivatives and their pharmaceutical use |
| 04/16/1991 | US5008257 Brain-specific drug delivery |
| 04/16/1991 | US5008243 Controlling metabolism and/or production of prostaglandins |
| 04/16/1991 | US5008241 Amino acid replacements provide increased charge at neutral pH and stability at acid pH |
| 04/16/1991 | US5008240 Polypeptide with amino acid sequence of cartilage inducing factor A or B |
| 04/16/1991 | US5008198 Hybridoma cell line producing monoclonal antibodies binding to antigens isolated from Plasmodium falciparum |
| 04/16/1991 | US5008196 Using purified vascular permeability factor of a protein dimer having mitogenic activity in culture |
| 04/16/1991 | US5008194 nifH promoters of Bradyrhizobium |
| 04/16/1991 | US5007925 Prosthetic devices coated with polypeptides with type IV collagen activity |
| 04/16/1991 | CA1283249C Process for the resolution of racemates of optically active bicyclic imino- -carboxylic esters, and the use of the compounds thus obtainable for the synthesis of carboxyalkyldipeptides |
| 04/16/1991 | CA1283248C Substrates for hydrolases, a method for their preparation and their use |
| 04/16/1991 | CA1283073C Adsorbent for purification of blood coagulation factor viii and process for purification of blood coagulation factor viii using the same |
| 04/16/1991 | CA1283072C Process for the isolation and separation of lysozyme and avidin from eggwhite |
| 04/16/1991 | CA1283069C Vector capable of efficient gene expression and utilization of suchvector |
| 04/16/1991 | CA1283048C Therapeutic agent for treating hematopoietic diseases |
| 04/16/1991 | CA1283045C Therapeutic and diagnostic methods using soluble t cell surface molecules |
| 04/16/1991 | CA1283043C T-cell lymphotrophic virus protein and assay |
| 04/14/1991 | WO1991005839A1 Dye transfer inhibition |
| 04/14/1991 | WO1991005754A2 Derivatives of long-chain fatty alcohols and their applications, in particular as cytotrophic and cytoprotective molecules, and pharmaceutical compositions containing same |
| 04/14/1991 | CA2044162A1 Long-chained fatty alcohol derivatives, their applications, specifically as cytotrphic and cytoprotecting molecules, and pharmaceutical compounds containing same |
| 04/14/1991 | CA2027315A1 Fibrinogen receptor antagonists |
| 04/14/1991 | CA2027314A1 Fibrinogen receptor antagonists |
| 04/13/1991 | WO1991005801A1 Dopamine releasing protein |
| 04/13/1991 | CA2065442A1 Dopamine releasing protein |
| 04/13/1991 | CA2027455A1 Hiv related peptides |
| 04/11/1991 | WO1991005806A1 Interfacial condensation of bioactive compounds and the site-specific compounds and conjugates thereof |
| 04/11/1991 | DE3932311A1 Purifying equine interferon beta - using anion and cation-exchange columns, useful for antiviral or immuno:modulatory medicament |
| 04/11/1991 | DE3932310A1 New hybrid cell lines producing MABS to equine interferon-beta - for diagnosis of EQIFN-bets esp. enzyme immunoassays or therapy |
| 04/11/1991 | DE3925748A1 New recombinant deoxyribonucleic acid - from foot=and=mouth disease virus, for prodn. of attenuated virus particles, useful in vaccines |
| 04/11/1991 | CA2067210A1 Interfacial condensation of bioactive compounds and the site-specific compounds and conjugates thereof |
| 04/11/1991 | CA2027126A1 Compositions and methods for treating or preventing infections in canine and feline animals |
| 04/11/1991 | CA2025231A1 Cancer marker and monoclonal antibodies specific therefor |
| 04/10/1991 | EP0421949A1 Chemically modified allergens and process for the preparation thereof |
| 04/10/1991 | EP0421935A2 Insect neuropeptides |
| 04/10/1991 | EP0421919A2 Polygalacturonase encoding fungal expression system |
| 04/10/1991 | EP0421876A1 Use of active agents in the preparation of a drug for the treatment of lymphomes or related diseases |
| 04/10/1991 | EP0421635A1 Chimaeric hepadnavirus core antigen proteins |
| 04/10/1991 | EP0421626A1 Vaccine for aids and hepatitis B |
| 04/10/1991 | EP0421455A1 A mutein of HST-1 and production thereof |
| 04/10/1991 | EP0421367A1 Anticoagulant peptides |
| 04/10/1991 | EP0421366A1 Radiolabeled anticoagulant peptides |
| 04/10/1991 | EP0421284A1 Human endothelin-3 cDNA and use thereof |
| 04/10/1991 | EP0421109A2 Screening methods for protease inhibitors |
| 04/10/1991 | EP0421099A2 Methods for modulating promoter responsible for beta amyloid precursor protein expression |
| 04/10/1991 | EP0421059A1 Purified ciliary neurotrophic factor |
| 04/10/1991 | EP0420964A1 Lyophilized peptide formulations |
| 04/10/1991 | EP0420911A1 Gene therapy using gene fusions for genetic or acquired disorders. |
| 04/10/1991 | EP0420894A1 Large scale method for purification of high purity heparinase. |
| 04/10/1991 | EP0277212A4 Diagnostic assay for inhibitor of tissue-type and urokinase-type plasminogen activators, and gene coding for the inhibitor |
| 04/10/1991 | CN1050561A Recombinant adenovirus dna sequence, recombinant adenovirus expressing dna sequence and rhabdovirus vaccine including recombinant adenovirus |
| 04/10/1991 | CN1050545A Inhibitor of retroinfection viral protease |
| 04/09/1991 | US5006652 Intermediates for antibody-vinca drug conjugates |
| 04/09/1991 | US5006642 Purification of von Willebrand Factor by affinity chromatography |
| 04/09/1991 | US5006469 Vectors and host cells expressing prepromotilin and motilin-associated peptide (MAP) |
| 04/09/1991 | US5006465 Cloning of gene |
| 04/09/1991 | US5006459 Immunoassays |
| 04/09/1991 | US5006336 Novel coleopteran-active bacillus thuringiensis isolate |
| 04/09/1991 | US5006334 Antigenic modification of polypeptides |
| 04/09/1991 | US5006287 Affinity membranes having pendant hydroxy groups and processes for the preparation and use thereof |
| 04/09/1991 | US5006256 Affinity membranes having pendant hydroxy groups and processes for the preparation and use thereof |
| 04/09/1991 | US5006252 Purified protease nexin |
| 04/09/1991 | US5005655 Partially halogenated ethane solvent removal of oleophylic materials from mineral particles |
| 04/09/1991 | CA1282721C Herpes simplex virus as a vector |
| 04/09/1991 | CA1282696C Purification of hepatitis pre-s antigens by polymerized serum albumin affinity binding |
| 04/09/1991 | CA1282691C Monoclonal antibodies useful in the identification of microorganisms causing periodontal disease |
| 04/07/1991 | WO1991005536A2 Novel oxidized lipoproteins and methods for their preparation |
| 04/07/1991 | WO1991005043A1 Cytolysis inhibitor proteins (cli) and dna sequences coding for said proteins |
| 04/07/1991 | WO1991004744A1 Methods and apparatus for treating disease states using oxidized lipoproteins |
| 04/07/1991 | CA2067364A1 Oxidized lipoproteins and methods for their preparation |
| 04/07/1991 | CA2067356A1 Methods for treating diseases using oxidized lipoproteins |
| 04/07/1991 | CA2042605A1 Cytolysis inhibitor proteins (cli), dna sequences coding for said proteins, and plasmids, host organisms, and processes for obtaining said proteins |
| 04/07/1991 | CA2027077A1 Application of active substances for the preparation of a drug for the treatment of lymphomas or related diseases, the drugs thus obtained and a process for the therapeutic treatment of lymphomas |
| 04/07/1991 | CA2027022A1 Compounds useful for measuring low levels of sulfonylureas by immunoassay |
| 04/04/1991 | WO1991004493A1 Hiv-related epitopes for diagnosis and immunoprotection |
| 04/04/1991 | WO1991004490A1 Hybridoma ct43 producing a monoclonal antibody to a mucin epitope of colorectal cancer |
| 04/04/1991 | WO1991004341A1 Hdv-specific peptides |
| 04/04/1991 | WO1991004339A1 Assays and reagents for amyloid deposition |